
Robert A. Wax
Supervisory Patent Examiner (ID: 6291, Phone: (571)272-0623 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1653, 1805, 1507, 1506, 1814, 1615, 1105, 1652, 1808, 1656, 1807 |
| Total Applications | 1615 |
| Issued Applications | 927 |
| Pending Applications | 419 |
| Abandoned Applications | 277 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5045640
[patent_doc_number] => 20070264313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Methods and compositions relating to animal dietary acids'
[patent_app_type] => utility
[patent_app_number] => 11/436391
[patent_app_country] => US
[patent_app_date] => 2006-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5366
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264313.pdf
[firstpage_image] =>[orig_patent_app_number] => 11436391
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/436391 | Methods and compositions relating to animal dietary acids | May 17, 2006 | Abandoned |
Array
(
[id] => 5834273
[patent_doc_number] => 20060246103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Implantable devices for the delivery of therapeutic agents to an orthopaedic surgical site'
[patent_app_type] => utility
[patent_app_number] => 11/434472
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5176
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246103.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434472
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434472 | Implantable devices for the delivery of therapeutic agents to an orthopaedic surgical site | May 14, 2006 | Abandoned |
Array
(
[id] => 5889810
[patent_doc_number] => 20060276396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Albumin fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 11/429373
[patent_app_country] => US
[patent_app_date] => 2006-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 208597
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276396.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429373
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429373 | Albumin fusion proteins | May 7, 2006 | Issued |
Array
(
[id] => 5224737
[patent_doc_number] => 20070254003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Non-sticky coatings with therapeutic agents for medical devices'
[patent_app_type] => utility
[patent_app_number] => 11/416488
[patent_app_country] => US
[patent_app_date] => 2006-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10797
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254003.pdf
[firstpage_image] =>[orig_patent_app_number] => 11416488
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/416488 | Non-sticky coatings with therapeutic agents for medical devices | Apr 30, 2006 | Abandoned |
Array
(
[id] => 5694192
[patent_doc_number] => 20060154339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Novel clock gene BMAL2'
[patent_app_type] => utility
[patent_app_number] => 11/374725
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15084
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154339.pdf
[firstpage_image] =>[orig_patent_app_number] => 11374725
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/374725 | Clock gene BMAL2 | Mar 12, 2006 | Issued |
Array
(
[id] => 5914093
[patent_doc_number] => 20060128947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/337518
[patent_app_country] => US
[patent_app_date] => 2006-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 16111
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128947.pdf
[firstpage_image] =>[orig_patent_app_number] => 11337518
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/337518 | Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor | Jan 23, 2006 | Issued |
Array
(
[id] => 5705679
[patent_doc_number] => 20060194727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Prevention and reduction of blood loss'
[patent_app_type] => utility
[patent_app_number] => 11/322960
[patent_app_country] => US
[patent_app_date] => 2005-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12057
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194727.pdf
[firstpage_image] =>[orig_patent_app_number] => 11322960
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/322960 | Prevention and reduction of blood loss | Dec 29, 2005 | Abandoned |
Array
(
[id] => 5613949
[patent_doc_number] => 20060115877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Hyaluronate synthase gene and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/321991
[patent_app_country] => US
[patent_app_date] => 2005-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21025
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115877.pdf
[firstpage_image] =>[orig_patent_app_number] => 11321991
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/321991 | Hyaluronate synthase gene and uses thereof | Dec 28, 2005 | Abandoned |
Array
(
[id] => 477504
[patent_doc_number] => 07223440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-29
[patent_title] => 'Residual solvent extraction method and microparticles produced thereby'
[patent_app_type] => utility
[patent_app_number] => 11/312371
[patent_app_country] => US
[patent_app_date] => 2005-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10166
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/223/07223440.pdf
[firstpage_image] =>[orig_patent_app_number] => 11312371
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/312371 | Residual solvent extraction method and microparticles produced thereby | Dec 20, 2005 | Issued |
Array
(
[id] => 415113
[patent_doc_number] => 07279309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-09
[patent_title] => 'Process for manufacture of Nematode-extracted Anticoagulant Protein (NAP)'
[patent_app_type] => utility
[patent_app_number] => 11/313303
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13519
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/279/07279309.pdf
[firstpage_image] =>[orig_patent_app_number] => 11313303
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/313303 | Process for manufacture of Nematode-extracted Anticoagulant Protein (NAP) | Dec 19, 2005 | Issued |
Array
(
[id] => 489799
[patent_doc_number] => 07214661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-08
[patent_title] => 'Methods of therapy with thrombin derived peptides'
[patent_app_type] => utility
[patent_app_number] => 11/293495
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5626
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/214/07214661.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293495
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293495 | Methods of therapy with thrombin derived peptides | Dec 1, 2005 | Issued |
Array
(
[id] => 5661002
[patent_doc_number] => 20060251598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'System for improved percutaneous absorption of skin benefiting agents'
[patent_app_type] => utility
[patent_app_number] => 11/291223
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4067
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251598.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291223
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291223 | System for improved percutaneous absorption of skin benefiting agents | Nov 30, 2005 | Abandoned |
Array
(
[id] => 422030
[patent_doc_number] => 07273962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-25
[patent_title] => 'Compositions and methods for removing heavy metals from contaminated samples using membranes provided with purified metallothionein (MT) proteins'
[patent_app_type] => utility
[patent_app_number] => 11/255427
[patent_app_country] => US
[patent_app_date] => 2005-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 13616
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/273/07273962.pdf
[firstpage_image] =>[orig_patent_app_number] => 11255427
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/255427 | Compositions and methods for removing heavy metals from contaminated samples using membranes provided with purified metallothionein (MT) proteins | Oct 18, 2005 | Issued |
Array
(
[id] => 5766876
[patent_doc_number] => 20060018924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Hyaluronan synthase gene and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/228079
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22283
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11228079
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/228079 | Hyaluronan synthase gene and uses thereof | Sep 15, 2005 | Issued |
Array
(
[id] => 5793148
[patent_doc_number] => 20060013829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Hyaluronan synthase gene and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/226480
[patent_app_country] => US
[patent_app_date] => 2005-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 28218
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20060013829.pdf
[firstpage_image] =>[orig_patent_app_number] => 11226480
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/226480 | Hyaluronan synthase gene and uses thereof | Sep 13, 2005 | Issued |
Array
(
[id] => 7605221
[patent_doc_number] => 07115708
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'β-Superfamily conotoxins'
[patent_app_type] => utility
[patent_app_number] => 11/198847
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24695
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115708.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198847
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198847 | β-Superfamily conotoxins | Aug 7, 2005 | Issued |
Array
(
[id] => 5807725
[patent_doc_number] => 20060094079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Protein for blocking platelet adhesion'
[patent_app_type] => utility
[patent_app_number] => 11/153433
[patent_app_country] => US
[patent_app_date] => 2005-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7603
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094079.pdf
[firstpage_image] =>[orig_patent_app_number] => 11153433
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/153433 | Protein for blocking platelet adhesion | Jun 15, 2005 | Issued |
Array
(
[id] => 5770559
[patent_doc_number] => 20050266471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Common marmoset-derived beta-actin gene and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/139406
[patent_app_country] => US
[patent_app_date] => 2005-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16489
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20050266471.pdf
[firstpage_image] =>[orig_patent_app_number] => 11139406
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/139406 | Common marmoset-derived beta-actin gene and use thereof | May 26, 2005 | Issued |
Array
(
[id] => 6977851
[patent_doc_number] => 20050287569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'EspFu nucleic acids and proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/134563
[patent_app_country] => US
[patent_app_date] => 2005-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23233
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287569.pdf
[firstpage_image] =>[orig_patent_app_number] => 11134563
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/134563 | EspFu nucleic acids and proteins and uses thereof | May 19, 2005 | Issued |
Array
(
[id] => 638006
[patent_doc_number] => 07125961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-24
[patent_title] => 'Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex'
[patent_app_type] => utility
[patent_app_number] => 11/131684
[patent_app_country] => US
[patent_app_date] => 2005-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 21
[patent_no_of_words] => 9135
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/125/07125961.pdf
[firstpage_image] =>[orig_patent_app_number] => 11131684
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/131684 | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex | May 16, 2005 | Issued |